| Hans-Günter Meyer-Thompson | Naloxon
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation.
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation.
Randall A, Hull I, Martin SA.
J Addict Med. 2022 Sep 23. doi: 10.1097/ADM.0000000000001073. Epub ahead of print. PMID: 36149001.
https://journals.lww.com/journaladdictionmedicine/Fulltext/9900/Enhancing_Patient_Choice__Using_Self_administered.83.aspx